Study to confirm clinical benefit of Silk Vista and Silk Vista Baby in a wide range of anatomical locations BOSTON, July 28, 2021 (GLOBE NEWSWIRE) — Balt, an innovative neurovascular company focused on developing, designing, and manufacturing solutions for treating complex, life-threatening conditions, including stroke, aneurysms, and arteriovenous malformations, today […]
Other News
Gencaro Atrial Fibrillation Phase 2B Results Selected for Publication in Circulation: Arrhythmia and Electrophysiology
Analysis in full patient cohort shows Gencaro effect compared to standard of care In the GENETIC-AF entire cohort of heart failure patients treated with Gencaro, compared to patients treated with metoprolol succinate (TOPROL-XL), experienced: a 36% reduction in cumulative atrial fibrillation burden with a 55% reduction in daily atrial fibrillation […]
Paragonix Technologies Announces Global Registry for Pediatric Donor Heart Preservation; Enrolls First Patient
University of Florida Health (UF Health) enrolls first patient in the study to further understanding of how advanced donor organ preservation impacts pediatric patient outcomes CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies, Inc. today announces that the University of Florida Health (UF Health) is the first to enroll a pediatric heart transplant recipient […]
Armor Bionics Signs Exclusive 3D Printing Deal with Shapeways to Transform Surgical Pre-Planning
Shapeways to provide 3D printed advanced medical models to be used for pre-planning surgeries Parts printed and expected to be delivered within 24 hours to meet stringent medical timetables Complex 3D printed medical models created for patient-specific treatment 3D printed medical model helped plan life-saving surgery for eight-month-old Less surgery […]
MicroPort® Cardiac Rhythm Management Business Announces US$150 Million Series C Investment
SHANGHAI, July 27, 2021 /PRNewswire/ — MicroPort Scientific Corporation (“MicroPort®“) announced that MicroPort Cardiac Rhythm Management Limited (“MicroPort® CRM“), which is MicroPort®‘s subsidiary focused on developing and commercializing implantable pacemaker and defibrillator devices and related technologies to manage cardiac rhythm disorders, has entered into definitive agreements in connection with its Series C financing […]
AliveCor and Acutus Medical Partner to Evaluate Management and Treatment of Cardiac Arrhythmias
Collaboration Aims to Explore Benefits of Remote Monitoring of Patients Pre- and Post-Ablation MOUNTAIN VIEW, Calif., July 27, 2021 /PRNewswire/ — AliveCor, Inc. (“AliveCor”), a leading innovator in FDA-cleared personal electrocardiogram (ECG) technology and services, and Acutus Medical (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today […]
AngelMed Announces First Commercial Implantation of Real-Time Heart Attack Warning System
The Guardian™ System continuously monitors heart rhythm, immediately alerting patients of any changes EATONTOWN, N.J., July 27, 2021 /PRNewswire/ — Angel Medical Systems, Inc., (dba AngelMed) a proactive diagnostics company focused on the advancement of long-term management of high-risk coronary disease, announced today the first commercial implantation and U.S. launch of its flagship […]
Boston Scientific Announces Results For Second Quarter 2021
MARLBOROUGH, Mass., July 27, 2021 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.077 billion during the second quarter of 2021, growing 53.6 percent on a reported basis, 49.6 percent on an operational1 basis and 52.4 percent on an organic2 basis, all compared to the prior year period. The company reported GAAP net income […]
CorMatrix® Cardiovascular, Inc. Completes Growth Financing Led by Jam Capital Partners
Leading Developer of Regenerative Cardiovascular Products to Complete FDA Clinical Trial and Advance Other Technologies in Treatment of Heart Disease ATLANTA, July 27, 2021 /PRNewswire/ — CorMatrix® Cardiovascular, Inc., (www.cormatrix.com) is a leading developer of regenerative cardiovascular products and is working on a portfolio of groundbreaking regenerative heart valve products for individuals with valve […]
MiRus™ Raises $65 Million For Expansion of Rhenium-based Medical Devices
ATLANTA, July 27, 2021 /PRNewswire/ — MiRus LLC, a commercial stage life sciences company, has completed a highly oversubscribed funding round for growth of its spine and extremity portfolios and development of structural heart disease solutions using its proprietary Rhenium-based alloys (MoRe®). The round was led by Mammoth Scientific and multi-generational family offices […]



